Global Rapid Influenza Diagnostic Test (RIDT) Market Research Report 2026(Status And Outlook)

Buy Now
Share to
Facebook
Twitter
LinkedIn
WhatsApp
Base Year
2026
Forecast Period
2024-2029
Pages
170
Industry
Diagnostics
Regions
Global
Updated
April 2026

Report Overview


Report Overview
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Rapid Influenza Diagnostic Test (RIDT) competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.Rapid Influenza Diagnostic Tests (RIDTs) are in vitro diagnostic products based on immunochromatographic or immunofluorescence technology, designed to qualitatively detect the presence of Influenza A and B nucleoprotein antigens in respiratory specimens within 30 minutes. Product formats mainly include lateral-flow cassette tests, fluorescent immunoassay cartridges, and multiplex panels (e.g., Flu A/B + SARS-CoV-2). Upstream materials primarily consist of monoclonal and polyclonal antibodies, antigen controls, nitrocellulose membranes, plastic housings, and buffer reagents, supplied by specialized reagent and medical consumable manufacturers. Downstream clients include hospital laboratories, community clinics, pharmacies and OTC retailers, public health agencies, and home-testing users.Based on due-diligence estimates, the global RIDT market in 2024 had an installed production capacity of approximately 320 million units, with sales of around 256 million units. The average selling price was about USD 4.5 per unit, and the average gross margin was approximately 67%. The market continues to grow steadily, driven by recurring flu seasons, enhanced epidemic surveillance, and rising demand for rapid self-testing. With the adoption of multiplex combo tests (e.g., Flu/COVID/RSV) and more sensitive fluorescent immunoassay platforms, the industry is expected to experience further consolidation and technological upgrading.At present, the global Rapid Influenza Diagnostic Test (RIDT) market is experiencing steady expansion. Frequent mutations in influenza virus strains and the predictable recurrence of seasonal flu outbreaks have increased the demand for rapid testing among public health systems and medical institutions worldwide. RIDTs are gaining wider adoption across hospitals, community clinics, and home-testing scenarios. Since the COVID-19 pandemic, public awareness and acceptance of respiratory virus rapid testing have grown substantially, further driving RIDT utilization. In addition, regulatory authorities in several countries have relaxed approval processes for over-the-counter (OTC) diagnostic products, enabling faster penetration of home-use testing kits.Looking ahead, the RIDT market is expected to evolve toward multiplex detection and higher sensitivity. With technological advancements, more manufacturers are integrating influenza testing with other respiratory pathogens such as COVID-19, RSV, and adenovirus, allowing “one-sample, multi-target” diagnostics. The integration of digital connectivity will enable real-time data transmission and improve epidemic surveillance efficiency. Meanwhile, emerging Asian markets—supported by large populations and improving primary healthcare infrastructure—are anticipated to become the main growth drivers for global RIDT demand.Nevertheless, several challenges remain. RIDTs still show lower sensitivity and specificity compared with molecular diagnostic methods such as RT-PCR, leading to potential false negatives in some cases. Price fluctuations in raw materials, high supplier concentration, and varying regulatory standards across regions can increase operational risks and cost pressures for manufacturers. Additionally, rising product homogeneity intensifies market competition, making it difficult for smaller players to achieve economies of scale. Going forward, industry growth will increasingly depend on continuous technological innovation, product diversification, and robust compliance in quality management and regulatory frameworks.

The global Rapid Influenza Diagnostic Test (RIDT) market size was estimated at USD 1152.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.90% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Rapid Influenza Diagnostic Test (RIDT) market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Rapid Influenza Diagnostic Test (RIDT) market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Rapid Influenza Diagnostic Test (RIDT) market.
Global Rapid Influenza Diagnostic Test (RIDT) Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
BD
Abbott
Quidel
Actim
Denka
Roche
Thermo Fisher Scientific
Meridian Bioscience
Sekisui Diagnostics
Princeton BioMeditech
Access Bio
Response Biomedical
Guangzhou Wondfo Biotech
Jiangsu Bioperfectus Technologies
Hangzhou Biotest Biotech
Wantai BioPharm
Daan Gene
Kehua Bio-Engineering
Zhuhai Encode Medical Engineering

Market Segmentation (by Type)
Immunochromatography
Colloidal Gold Method
Others

Market Segmentation (by Application)
Hospital
Clinics
Home
Others

Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Rapid Influenza Diagnostic Test (RIDT) Market
Overview of the regional outlook of the Rapid Influenza Diagnostic Test (RIDT) Market:

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Rapid Influenza Diagnostic Test (RIDT) Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the markets competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Rapid Influenza Diagnostic Test (RIDT), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



Table of Contents

  • 1 Research Methodology and Statistical Scope
    • 1.1 Market Definition and Statistical Scope of Rapid Influenza Diagnostic Test (RIDT)
    • 1.2 Key Market Segments
      • 1.2.1 Rapid Influenza Diagnostic Test (RIDT) Segment by Type
      • 1.2.2 Rapid Influenza Diagnostic Test (RIDT) Segment by Application
    • 1.3 Methodology & Sources of Information
      • 1.3.1 Research Methodology
      • 1.3.2 Research Process
      • 1.3.3 Market Breakdown and Data Triangulation
      • 1.3.4 Base Year
      • 1.3.5 Report Assumptions & Caveats
  • 2 Rapid Influenza Diagnostic Test (RIDT) Market Overview
    • 2.1 Global Market Overview
      • 2.1.1 Global Rapid Influenza Diagnostic Test (RIDT) Market Size (M USD) Estimates and Forecasts (2020-2035)
      • 2.1.2 Global Rapid Influenza Diagnostic Test (RIDT) Sales Estimates and Forecasts (2020-2035)
    • 2.2 Market Segment Executive Summary
    • 2.3 Global Market Size by Region
  • 3 Rapid Influenza Diagnostic Test (RIDT) Market Competitive Landscape
    • 3.1 Company Assessment Quadrant
    • 3.2 Global Rapid Influenza Diagnostic Test (RIDT) Product Life Cycle
    • 3.3 Global Rapid Influenza Diagnostic Test (RIDT) Sales by Manufacturers (2020-2025)
    • 3.4 Global Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share by Manufacturers (2020-2025)
    • 3.5 Rapid Influenza Diagnostic Test (RIDT) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.6 Global Rapid Influenza Diagnostic Test (RIDT) Average Price by Manufacturers (2020-2025)
    • 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
    • 3.8 Rapid Influenza Diagnostic Test (RIDT) Market Competitive Situation and Trends
      • 3.8.1 Rapid Influenza Diagnostic Test (RIDT) Market Concentration Rate
      • 3.8.2 Global 5 and 10 Largest Rapid Influenza Diagnostic Test (RIDT) Players Market Share by Revenue
      • 3.8.3 Mergers & Acquisitions, Expansion
  • 4 Rapid Influenza Diagnostic Test (RIDT) Industry Chain Analysis
    • 4.1 Rapid Influenza Diagnostic Test (RIDT) Industry Chain Analysis
    • 4.2 Market Overview of Key Raw Materials
    • 4.3 Midstream Market Analysis
    • 4.4 Downstream Customer Analysis
  • 5 The Development and Dynamics of Rapid Influenza Diagnostic Test (RIDT) Market
    • 5.1 Key Development Trends
    • 5.2 Driving Factors
    • 5.3 Market Challenges
    • 5.4 Industry News
      • 5.4.1 New Product Developments
      • 5.4.2 Mergers & Acquisitions
      • 5.4.3 Expansions
      • 5.4.4 Collaboration/Supply Contracts
    • 5.5 PEST Analysis
      • 5.5.1 Industry Policies Analysis
      • 5.5.2 Economic Environment Analysis
      • 5.5.3 Social Environment Analysis
      • 5.5.4 Technological Environment Analysis
    • 5.6 Global Rapid Influenza Diagnostic Test (RIDT) Market Porters Five Forces Analysis
      • 5.6.1 Global Trade Frictions
      • 5.6.2 U.S. Tariff Policy – April 2025
      • 5.6.3 Global Trade Frictions and Their Impacts to Rapid Influenza Diagnostic Test (RIDT) Market
    • 5.7 ESG Ratings of Leading Companies
  • 6 Rapid Influenza Diagnostic Test (RIDT) Market Segmentation by Type
    • 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
    • 6.2 Global Rapid Influenza Diagnostic Test (RIDT) Sales Market Share by Type (2020-2025)
    • 6.3 Global Rapid Influenza Diagnostic Test (RIDT) Market Size by Type (2020-2025)
    • 6.4 Global Rapid Influenza Diagnostic Test (RIDT) Price by Type (2020-2025)
  • 7 Rapid Influenza Diagnostic Test (RIDT) Market Segmentation by Application
    • 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
    • 7.2 Global Rapid Influenza Diagnostic Test (RIDT) Market Sales by Application (2020-2025)
    • 7.3 Global Rapid Influenza Diagnostic Test (RIDT) Market Size (M USD) by Application (2020-2025)
    • 7.4 Global Rapid Influenza Diagnostic Test (RIDT) Sales Growth Rate by Application (2020-2025)
  • 8 Rapid Influenza Diagnostic Test (RIDT) Market Sales by Region
    • 8.1 Global Rapid Influenza Diagnostic Test (RIDT) Sales by Region
      • 8.1.1 Global Rapid Influenza Diagnostic Test (RIDT) Sales by Region
      • 8.1.2 Global Rapid Influenza Diagnostic Test (RIDT) Sales Market Share by Region
    • 8.2 Global Rapid Influenza Diagnostic Test (RIDT) Market Size by Region
      • 8.2.1 Global Rapid Influenza Diagnostic Test (RIDT) Market Size by Region
      • 8.2.2 Global Rapid Influenza Diagnostic Test (RIDT) Market Size by Region
    • 8.3 North America
      • 8.3.1 North America Rapid Influenza Diagnostic Test (RIDT) Sales by Country
      • 8.3.2 North America Rapid Influenza Diagnostic Test (RIDT) Market Size by Country
      • 8.3.3 U.S. Market Overview
      • 8.3.4 Canada Market Overview
      • 8.3.5 Mexico Market Overview
    • 8.4 Europe
      • 8.4.1 Europe Rapid Influenza Diagnostic Test (RIDT) Sales by Country
      • 8.4.2 Europe Rapid Influenza Diagnostic Test (RIDT) Market Size by Country
      • 8.4.3 Germany Market Overview
      • 8.4.4 France Market Overview
      • 8.4.5 U.K. Market Overview
      • 8.4.6 Italy Market Overview
      • 8.4.7 Spain Market Overview
    • 8.5 Asia Pacific
      • 8.5.1 Asia Pacific Rapid Influenza Diagnostic Test (RIDT) Sales by Region
      • 8.5.2 Asia Pacific Rapid Influenza Diagnostic Test (RIDT) Market Size by Region
      • 8.5.3 China Market Overview
      • 8.5.4 Japan Market Overview
      • 8.5.5 South Korea Market Overview
      • 8.5.6 India Market Overview
      • 8.5.7 Southeast Asia Market Overview
    • 8.6 South America
      • 8.6.1 South America Rapid Influenza Diagnostic Test (RIDT) Sales by Country
      • 8.6.2 South America Rapid Influenza Diagnostic Test (RIDT) Market Size by Country
      • 8.6.3 Brazil Market Overview
      • 8.6.4 Argentina Market Overview
      • 8.6.5 Columbia Market Overview
    • 8.7 Middle East and Africa
      • 8.7.1 Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) Sales by Region
      • 8.7.2 Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) Market Size by Region
      • 8.7.3 Saudi Arabia Market Overview
      • 8.7.4 UAE Market Overview
      • 8.7.5 Egypt Market Overview
      • 8.7.6 Nigeria Market Overview
      • 8.7.7 South Africa Market Overview
  • 9 Rapid Influenza Diagnostic Test (RIDT) Market Production by Region
    • 9.1 Global Production of Rapid Influenza Diagnostic Test (RIDT) by Region(2020-2025)
    • 9.2 Global Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share by Region (2020-2025)
    • 9.3 Global Rapid Influenza Diagnostic Test (RIDT) Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.4 North America Rapid Influenza Diagnostic Test (RIDT) Production
      • 9.4.1 North America Rapid Influenza Diagnostic Test (RIDT) Production Growth Rate (2020-2025)
      • 9.4.2 North America Rapid Influenza Diagnostic Test (RIDT) Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.5 Europe Rapid Influenza Diagnostic Test (RIDT) Production
      • 9.5.1 Europe Rapid Influenza Diagnostic Test (RIDT) Production Growth Rate (2020-2025)
      • 9.5.2 Europe Rapid Influenza Diagnostic Test (RIDT) Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.6 Japan Rapid Influenza Diagnostic Test (RIDT) Production (2020-2025)
      • 9.6.1 Japan Rapid Influenza Diagnostic Test (RIDT) Production Growth Rate (2020-2025)
      • 9.6.2 Japan Rapid Influenza Diagnostic Test (RIDT) Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.7 China Rapid Influenza Diagnostic Test (RIDT) Production (2020-2025)
      • 9.7.1 China Rapid Influenza Diagnostic Test (RIDT) Production Growth Rate (2020-2025)
      • 9.7.2 China Rapid Influenza Diagnostic Test (RIDT) Production, Revenue, Price and Gross Margin (2020-2025)
  • 10 Key Companies Profile
    • 10.1 BD
      • 10.1.1 BD Basic Information
      • 10.1.2 BD Rapid Influenza Diagnostic Test (RIDT) Product Overview
      • 10.1.3 BD Rapid Influenza Diagnostic Test (RIDT) Product Market Performance
      • 10.1.4 BD Business Overview
      • 10.1.5 BD SWOT Analysis
      • 10.1.6 BD Recent Developments
    • 10.2 Abbott
      • 10.2.1 Abbott Basic Information
      • 10.2.2 Abbott Rapid Influenza Diagnostic Test (RIDT) Product Overview
      • 10.2.3 Abbott Rapid Influenza Diagnostic Test (RIDT) Product Market Performance
      • 10.2.4 Abbott Business Overview
      • 10.2.5 Abbott SWOT Analysis
      • 10.2.6 Abbott Recent Developments
    • 10.3 Quidel
      • 10.3.1 Quidel Basic Information
      • 10.3.2 Quidel Rapid Influenza Diagnostic Test (RIDT) Product Overview
      • 10.3.3 Quidel Rapid Influenza Diagnostic Test (RIDT) Product Market Performance
      • 10.3.4 Quidel Business Overview
      • 10.3.5 Quidel SWOT Analysis
      • 10.3.6 Quidel Recent Developments
    • 10.4 Actim
      • 10.4.1 Actim Basic Information
      • 10.4.2 Actim Rapid Influenza Diagnostic Test (RIDT) Product Overview
      • 10.4.3 Actim Rapid Influenza Diagnostic Test (RIDT) Product Market Performance
      • 10.4.4 Actim Business Overview
      • 10.4.5 Actim Recent Developments
    • 10.5 Denka
      • 10.5.1 Denka Basic Information
      • 10.5.2 Denka Rapid Influenza Diagnostic Test (RIDT) Product Overview
      • 10.5.3 Denka Rapid Influenza Diagnostic Test (RIDT) Product Market Performance
      • 10.5.4 Denka Business Overview
      • 10.5.5 Denka Recent Developments
    • 10.6 Roche
      • 10.6.1 Roche Basic Information
      • 10.6.2 Roche Rapid Influenza Diagnostic Test (RIDT) Product Overview
      • 10.6.3 Roche Rapid Influenza Diagnostic Test (RIDT) Product Market Performance
      • 10.6.4 Roche Business Overview
      • 10.6.5 Roche Recent Developments
    • 10.7 Thermo Fisher Scientific
      • 10.7.1 Thermo Fisher Scientific Basic Information
      • 10.7.2 Thermo Fisher Scientific Rapid Influenza Diagnostic Test (RIDT) Product Overview
      • 10.7.3 Thermo Fisher Scientific Rapid Influenza Diagnostic Test (RIDT) Product Market Performance
      • 10.7.4 Thermo Fisher Scientific Business Overview
      • 10.7.5 Thermo Fisher Scientific Recent Developments
    • 10.8 Meridian Bioscience
      • 10.8.1 Meridian Bioscience Basic Information
      • 10.8.2 Meridian Bioscience Rapid Influenza Diagnostic Test (RIDT) Product Overview
      • 10.8.3 Meridian Bioscience Rapid Influenza Diagnostic Test (RIDT) Product Market Performance
      • 10.8.4 Meridian Bioscience Business Overview
      • 10.8.5 Meridian Bioscience Recent Developments
    • 10.9 Sekisui Diagnostics
      • 10.9.1 Sekisui Diagnostics Basic Information
      • 10.9.2 Sekisui Diagnostics Rapid Influenza Diagnostic Test (RIDT) Product Overview
      • 10.9.3 Sekisui Diagnostics Rapid Influenza Diagnostic Test (RIDT) Product Market Performance
      • 10.9.4 Sekisui Diagnostics Business Overview
      • 10.9.5 Sekisui Diagnostics Recent Developments
    • 10.10 Princeton BioMeditech
      • 10.10.1 Princeton BioMeditech Basic Information
      • 10.10.2 Princeton BioMeditech Rapid Influenza Diagnostic Test (RIDT) Product Overview
      • 10.10.3 Princeton BioMeditech Rapid Influenza Diagnostic Test (RIDT) Product Market Performance
      • 10.10.4 Princeton BioMeditech Business Overview
      • 10.10.5 Princeton BioMeditech Recent Developments
    • 10.11 Access Bio
      • 10.11.1 Access Bio Basic Information
      • 10.11.2 Access Bio Rapid Influenza Diagnostic Test (RIDT) Product Overview
      • 10.11.3 Access Bio Rapid Influenza Diagnostic Test (RIDT) Product Market Performance
      • 10.11.4 Access Bio Business Overview
      • 10.11.5 Access Bio Recent Developments
    • 10.12 Response Biomedical
      • 10.12.1 Response Biomedical Basic Information
      • 10.12.2 Response Biomedical Rapid Influenza Diagnostic Test (RIDT) Product Overview
      • 10.12.3 Response Biomedical Rapid Influenza Diagnostic Test (RIDT) Product Market Performance
      • 10.12.4 Response Biomedical Business Overview
      • 10.12.5 Response Biomedical Recent Developments
    • 10.13 Guangzhou Wondfo Biotech
      • 10.13.1 Guangzhou Wondfo Biotech Basic Information
      • 10.13.2 Guangzhou Wondfo Biotech Rapid Influenza Diagnostic Test (RIDT) Product Overview
      • 10.13.3 Guangzhou Wondfo Biotech Rapid Influenza Diagnostic Test (RIDT) Product Market Performance
      • 10.13.4 Guangzhou Wondfo Biotech Business Overview
      • 10.13.5 Guangzhou Wondfo Biotech Recent Developments
    • 10.14 Jiangsu Bioperfectus Technologies
      • 10.14.1 Jiangsu Bioperfectus Technologies Basic Information
      • 10.14.2 Jiangsu Bioperfectus Technologies Rapid Influenza Diagnostic Test (RIDT) Product Overview
      • 10.14.3 Jiangsu Bioperfectus Technologies Rapid Influenza Diagnostic Test (RIDT) Product Market Performance
      • 10.14.4 Jiangsu Bioperfectus Technologies Business Overview
      • 10.14.5 Jiangsu Bioperfectus Technologies Recent Developments
    • 10.15 Hangzhou Biotest Biotech
      • 10.15.1 Hangzhou Biotest Biotech Basic Information
      • 10.15.2 Hangzhou Biotest Biotech Rapid Influenza Diagnostic Test (RIDT) Product Overview
      • 10.15.3 Hangzhou Biotest Biotech Rapid Influenza Diagnostic Test (RIDT) Product Market Performance
      • 10.15.4 Hangzhou Biotest Biotech Business Overview
      • 10.15.5 Hangzhou Biotest Biotech Recent Developments
    • 10.16 Wantai BioPharm
      • 10.16.1 Wantai BioPharm Basic Information
      • 10.16.2 Wantai BioPharm Rapid Influenza Diagnostic Test (RIDT) Product Overview
      • 10.16.3 Wantai BioPharm Rapid Influenza Diagnostic Test (RIDT) Product Market Performance
      • 10.16.4 Wantai BioPharm Business Overview
      • 10.16.5 Wantai BioPharm Recent Developments
    • 10.17 Daan Gene
      • 10.17.1 Daan Gene Basic Information
      • 10.17.2 Daan Gene Rapid Influenza Diagnostic Test (RIDT) Product Overview
      • 10.17.3 Daan Gene Rapid Influenza Diagnostic Test (RIDT) Product Market Performance
      • 10.17.4 Daan Gene Business Overview
      • 10.17.5 Daan Gene Recent Developments
    • 10.18 Kehua Bio-Engineering
      • 10.18.1 Kehua Bio-Engineering Basic Information
      • 10.18.2 Kehua Bio-Engineering Rapid Influenza Diagnostic Test (RIDT) Product Overview
      • 10.18.3 Kehua Bio-Engineering Rapid Influenza Diagnostic Test (RIDT) Product Market Performance
      • 10.18.4 Kehua Bio-Engineering Business Overview
      • 10.18.5 Kehua Bio-Engineering Recent Developments
    • 10.19 Zhuhai Encode Medical Engineering
      • 10.19.1 Zhuhai Encode Medical Engineering Basic Information
      • 10.19.2 Zhuhai Encode Medical Engineering Rapid Influenza Diagnostic Test (RIDT) Product Overview
      • 10.19.3 Zhuhai Encode Medical Engineering Rapid Influenza Diagnostic Test (RIDT) Product Market Performance
      • 10.19.4 Zhuhai Encode Medical Engineering Business Overview
      • 10.19.5 Zhuhai Encode Medical Engineering Recent Developments
  • 11 Rapid Influenza Diagnostic Test (RIDT) Market Forecast by Region
    • 11.1 Global Rapid Influenza Diagnostic Test (RIDT) Market Size Forecast
    • 11.2 Global Rapid Influenza Diagnostic Test (RIDT) Market Forecast by Region
      • 11.2.1 North America Market Size Forecast by Country
      • 11.2.2 Europe Rapid Influenza Diagnostic Test (RIDT) Market Size Forecast by Country
      • 11.2.3 Asia Pacific Rapid Influenza Diagnostic Test (RIDT) Market Size Forecast by Region
      • 11.2.4 South America Rapid Influenza Diagnostic Test (RIDT) Market Size Forecast by Country
      • 11.2.5 Middle East and Africa Forecasted Sales of Rapid Influenza Diagnostic Test (RIDT) by Country
  • 12 Forecast Market by Type and by Application (2026-2035)
    • 12.1 Global Rapid Influenza Diagnostic Test (RIDT) Market Forecast by Type (2026-2035)
      • 12.1.1 Global Forecasted Sales of Rapid Influenza Diagnostic Test (RIDT) by Type (2026-2035)
      • 12.1.2 Global Rapid Influenza Diagnostic Test (RIDT) Market Size Forecast by Type (2026-2035)
      • 12.1.3 Global Forecasted Price of Rapid Influenza Diagnostic Test (RIDT) by Type (2026-2035)
    • 12.2 Global Rapid Influenza Diagnostic Test (RIDT) Market Forecast by Application (2026-2035)
      • 12.2.1 Global Rapid Influenza Diagnostic Test (RIDT) Sales (K Units) Forecast by Application
      • 12.2.2 Global Rapid Influenza Diagnostic Test (RIDT) Market Size (M USD) Forecast by Application (2026-2035)
  • 13 Conclusion and Key Findings

Frequently Asked Questions

JSB Market Research is a global provider of market research reports, industry insights, and business intelligence solutions. We help companies, analysts, and decision-makers gain a deeper understanding of global and regional markets.

Our reports deliver data-driven insights, market opportunities, competitive landscapes, and future forecasts. These help your business make informed decisions, enter new markets confidently, and stay ahead of industry trends.

Yes. We offer tailored research services designed to meet your specific market, product, or competitor analysis needs. Our experts work closely with clients to deliver precise, relevant, and actionable insights.

Browse the desired report, select your preferred license type, and complete payment through our secure checkout. For corporate purchases or invoice payments, you can contact our support team directly.

Yes. You can request sample pages or a report overview. This helps you understand the structure, methodology, and depth of analysis before purchasing.